This expert guidance document was created to help acute hospitals prioritize and implement strategies to address risk factors that may lead to ventilator-associated pneumonia (VAP), ventilator-associated events (VAE), and non-ventilator hospital-acquired pneumonia (NV-HAP). This 2022 update was based on initial recommendations published in 2014 and sponsored by the Society for Healthcare Epidemiology (SHEA). It is the product of a collaborative effort led by SHEA, the Infectious Diseases Society of America, the American Hospital Association (ICHE), the Association for Professionals in Infection Control an Epidemiology (APIC), and The Joint Commission, with major contributions from representatives of a number of organizations and societies with content expertise. This is a summary of this team’s recommendations for strategies to decrease NV-HAP.
Interventions that may lower NV-HAP rates with little risk of harm are:
Interventions with very little data that show impact on NV-HAP are:
This update is important as hospitals strive to improve safety and care for their patients. These strategies have been provided by a national, multidisciplinary team of experts to recommend best treatment practices and avoid outcomes associated with dangerous and costly hospital-acquired infections.
To read the full practice recommendation click here.
To learn more about products that can help address the risk factors for hospital-acquired pneumonia, click here.
Reference:
1. Klompas M, et al., Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update, Infection Control & Hospital Epidemiology, 2022, 43: 687-713.
765900